Author

Ioan Sporea

QUANTIFICATION OF LIVER STEATOSIS USING TWO DIFFERENT ULTRASOUND-BASED METHODS IN COMPARISON WITH CAP
QUANTIFICATION OF LIVER STEATOSIS USING TWO DIFFERENT ULTRASOUND-BASED METHODS IN COMPARISON WITH CAP

Ioan Sporea  et al.

Parenchymal liver disease – the role of elastography and attenuating imaging
Parenchymal liver disease – the role of elastography and attenuating imaging

Ioan Sporea

Liver pathology – diffuse changes
Liver pathology – diffuse changes

Ioan Sporea

FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS
FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS

Ioan Sporea  et al.

Diffuse liver pathology: The role of ultrasound, elastography and attenuating imaging
Diffuse liver pathology: The role of ultrasound, elastography and attenuating imaging

Ioan Sporea

STEATDIAB A SCORE FOR IDENTIFYING TYPE 2 DIABETES MELLITUS PATIENTS AT RISK FOR DEVELOPING MODERATE STEATOSIS
STEATDIAB A SCORE FOR IDENTIFYING TYPE 2 DIABETES MELLITUS PATIENTS AT RISK FOR DEVELOPING MODERATE STEATOSIS

Ioan Sporea  et al.

Position Paper on Treatment of Hepatitis C in Romania, 2017. Part One
Position Paper on Treatment of Hepatitis C in Romania, 2017. Part One

Ioan Sporea  et al.

PERFORMANCE OF A 2D-SWE IMPLEMENTED ON A NEW ULTRASOUND SYSTEM FOR ASSESSMENT OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AS THE REFERENCE METHOD
PERFORMANCE OF A 2D-SWE IMPLEMENTED ON A NEW ULTRASOUND SYSTEM FOR ASSESSMENT OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AS THE REFERENCE METHOD

Ioan Sporea  et al.

Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two
Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two

Ioan Sporea  et al.

MULTIMODAL MONITORING OF THE DEGREE OF HYPNOSIS DURING SEDATION AND ANESTHESIA FOR GI ENDOSCOPIC PROCEDURES - THE FUTURE IN PATIENT SAFETY
MULTIMODAL MONITORING OF THE DEGREE OF HYPNOSIS DURING SEDATION AND ANESTHESIA FOR GI ENDOSCOPIC PROCEDURES - THE FUTURE IN PATIENT SAFETY

Ioan Sporea  et al.

EVALUATION OF LIVER ALTERATIONS IN PATIENTS WITH POST-ACUTE COVID-19 SYNDROME - A PILOT STUDY
EVALUATION OF LIVER ALTERATIONS IN PATIENTS WITH POST-ACUTE COVID-19 SYNDROME - A PILOT STUDY

Ioan Sporea  et al.

LIVER FIBROSIS AND STEATOSIS ASSESSMENT USING ELASTOGRAPHIC TECHNIQUES: A COMPARISON BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND ALCOHOLIC LIVER DISEASE
LIVER FIBROSIS AND STEATOSIS ASSESSMENT USING ELASTOGRAPHIC TECHNIQUES: A COMPARISON BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND ALCOHOLIC LIVER DISEASE

Ioan Sporea  et al.

DIAGNOSTIC VALUE OF ENDOSCOPIC ULTRASOUND (EUS) GUIDED FINE NEEDLE BIOPSY (FNB) FOR DIFFUSE GASTRIC CARCINOMA
DIAGNOSTIC VALUE OF ENDOSCOPIC ULTRASOUND (EUS) GUIDED FINE NEEDLE BIOPSY (FNB) FOR DIFFUSE GASTRIC CARCINOMA

Ioan Sporea  et al.

PARAMETRIC ARRIVAL TIME (PAT) IN RULING OUT SEVERE LIVER FIBROSIS
PARAMETRIC ARRIVAL TIME (PAT) IN RULING OUT SEVERE LIVER FIBROSIS

Ioan Sporea  et al.

FIBROSIS PREDICTIVE SCORE IN PATIENTS WITH METABOLIC SYNDROME
FIBROSIS PREDICTIVE SCORE IN PATIENTS WITH METABOLIC SYNDROME

Ioan Sporea  et al.

NONINVASIVE BIOLOGICAL STEATOSIS AND FIBROSIS SCORES, USEFUL TOOLS FOR EVALUATING MAFLD (METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE) PATIENTS
NONINVASIVE BIOLOGICAL STEATOSIS AND FIBROSIS SCORES, USEFUL TOOLS FOR EVALUATING MAFLD (METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE) PATIENTS

Ioan Sporea  et al.

HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?
HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?

Ioan Sporea  et al.

THE FREQUENCY AND IMPACT OF INFECTIONS IN PATIENTS WITH ALCOHOLIC HEPATITIS
THE FREQUENCY AND IMPACT OF INFECTIONS IN PATIENTS WITH ALCOHOLIC HEPATITIS

Ioan Sporea  et al.

PREDICTIVE SCORES IN PATIENTS WITH TYPE 2 DIABETES
PREDICTIVE SCORES IN PATIENTS WITH TYPE 2 DIABETES

Ioan Sporea  et al.

DAY-4 LILLE SCORE IN EARLY PREDICTION OF CORTICOSTEROID RESPONSE FOR PATIENTS WITH SEVERE ACUTE ALCOHOLIC HEPATITIS
DAY-4 LILLE SCORE IN EARLY PREDICTION OF CORTICOSTEROID RESPONSE FOR PATIENTS WITH SEVERE ACUTE ALCOHOLIC HEPATITIS

Ioan Sporea  et al.

Item 1 - 20 / 33
1
2